These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35962457)

  • 1. Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells.
    Álvarez-Palomo B; Veiga A; Raya A; Codinach M; Torrents S; Ponce Verdugo L; Rodriguez-Aierbe C; Cuellar L; Alenda R; Arbona C; Hernández-Maraver D; Fusté C; Querol S
    Stem Cell Res Ther; 2022 Aug; 13(1):408. PubMed ID: 35962457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population.
    Kuebler B; Alvarez-Palomo B; Aran B; Castaño J; Rodriguez L; Raya A; Querol Giner S; Veiga A
    Stem Cell Res Ther; 2023 Dec; 14(1):366. PubMed ID: 38093328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GMP-grade CD34
    Liedtke S; Korschgen L; Korn J; Duppers A; Kogler G
    Vox Sang; 2021 Jan; 116(1):123-135. PubMed ID: 32687634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical Cord Blood Units Cryopreserved in the Public Cord Blood Bank: A Breakthrough in iPSC Haplobanking?
    Roh EY; Oh S; Yoon JH; Kim BJ; Song EY; Shin S
    Cell Transplant; 2020; 29():963689720926151. PubMed ID: 32623908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells.
    Álvarez-Palomo B; García-Martinez I; Gayoso J; Raya A; Veiga A; Abad ML; Eiras A; Guzmán-Fulgencio M; Luis-Hidalgo M; Eguizabal C; Santos S; Balas A; Alenda R; Sanchez-Gordo F; Verdugo LP; Villa J; Carreras E; Vidal F; Madrigal A; Herrero MJ; Rudilla F; Querol S
    Stem Cell Res Ther; 2021 Apr; 12(1):233. PubMed ID: 33849662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the Hematopoietic Stem Cell Donor Pool as a Source of HLA-Homozygous Induced Pluripotent Stem Cells for Haplobanking: Combined Analysis of the Cord Blood Inventory and Bone Marrow Donor Registry.
    Shin S; Song EY; Kwon YW; Oh S; Park H; Kim NH; Roh EY
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):e202-e208. PubMed ID: 32439474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications.
    Abberton KM; McDonald TL; Diviney M; Holdsworth R; Leslie S; Delatycki MB; Liu L; Klamer G; Johnson P; Elwood NJ
    Stem Cells Transl Med; 2022 Oct; 11(10):1052-1060. PubMed ID: 36073721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
    Lee S; Huh JY; Turner DM; Lee S; Robinson J; Stein JE; Shim SH; Hong CP; Kang MS; Nakagawa M; Kaneko S; Nakanishi M; Rao MS; Kurtz A; Stacey GN; Marsh SGE; Turner ML; Song J
    Stem Cells; 2018 Oct; 36(10):1552-1566. PubMed ID: 30004605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood.
    Tian P; Elefanty A; Stanley EG; Durnall JC; Thompson LH; Elwood NJ
    Front Cell Dev Biol; 2022; 10():835321. PubMed ID: 35372371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea.
    Rim YA; Park N; Nam Y; Ham DS; Kim JW; Ha HY; Jung JW; Jung SM; Baek IC; Kim SY; Kim TG; Song J; Lee J; Park SH; Chung NG; Yoon KH; Ju JH
    J Tissue Eng Regen Med; 2018 Mar; 12(3):e1531-e1536. PubMed ID: 28941241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can cord blood banks transform into induced pluripotent stem cell banks?
    Zhou H; Rao MS
    Cytotherapy; 2015 Jun; 17(6):756-764. PubMed ID: 25770678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population.
    Pappas DJ; Gourraud PA; Le Gall C; Laurent J; Trounson A; DeWitt N; Talib S
    Stem Cells Transl Med; 2015 May; 4(5):413-8. PubMed ID: 25926330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.
    Baghbaderani BA; Syama A; Sivapatham R; Pei Y; Mukherjee O; Fellner T; Zeng X; Rao MS
    Stem Cell Rev Rep; 2016 Aug; 12(4):394-420. PubMed ID: 27283945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population.
    Yoshida S; Kato TM; Sato Y; Umekage M; Ichisaka T; Tsukahara M; Takasu N; Yamanaka S
    Med; 2023 Jan; 4(1):51-66.e10. PubMed ID: 36395757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings.
    Morishima Y; Morishima S; Murata M; Arima N; Uchida N; Sugio Y; Takahashi S; Matsuhashi Y; Onizuka M; Eto T; Nagafuji K; Onishi Y; Inoue M; Atsuta Y; Fukuda T; Ichinohe T; Kato S; Kanda J
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):132-138. PubMed ID: 31521817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cord blood banking activity in Iran National Cord Blood Bank: a two years experience.
    Jamali M; Atarodi K; Nakhlestani M; Abolghasemi H; Sadegh H; Faranoosh M; Golzade K; Fadai R; Niknam F; Zarif MN
    Transfus Apher Sci; 2014 Feb; 50(1):129-35. PubMed ID: 24262492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manufacturing Parameters for the Creation of Clinical-Grade Human-Induced Pluripotent Stem Cell Lines From Umbilical Cord Mesenchymal Stromal Cells.
    Beckenkamp LR; da Silva CG; Von Hohendorff MLI; Ogliari KS
    Stem Cells Transl Med; 2024 May; 13(5):454-461. PubMed ID: 38402590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified CD34+ hematopoietic stem and progenitor cell isolation strategy from cryopreserved human umbilical cord blood.
    Mata MF; Hernandez D; Rologi E; Grandolfo D; Hassan E; Hua P; Kallmeier R; Hirani S; Heuts F; Tittrea V; Choo Y; Baradez MO; Watt SM; Tarunina M
    Transfusion; 2019 Dec; 59(12):3560-3569. PubMed ID: 31769050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.
    Chicha L; Feki A; Boni A; Irion O; Hovatta O; Jaconi M
    PLoS One; 2011 Feb; 6(2):e14733. PubMed ID: 21364915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical products.
    Novoa JJ; Westra IM; Steeneveld E; Fonseca Neves N; Arendzen CH; Rajaei B; Grundeken E; Yildiz M; van der Valk W; Salvador A; Carlotti F; Dijkers PF; Locher H; van den Berg CW; Raymond KI; Kirkeby A; Mummery CL; Rabelink TJ; Freund C; Meij P; Wieles B
    Cytotherapy; 2024 Jun; 26(6):556-566. PubMed ID: 38483359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.